MSP1101 Citations (2)
Originally described in: Engineered CRISPR-Cas9 nucleases with altered PAM specificities.Kleinstiver BP, Prew MS, Tsai SQ, Topkar VV, Nguyen NT, Zheng Z, Gonzales AP, Li Z, Peterson RT, Yeh JJ, Aryee MJ, Joung JK Nature. 2015 Jun 22. doi: 10.1038/nature14592. PubMed Journal
Articles Citing MSP1101
| Articles |
|---|
Optimized base editors enable efficient editing in cells, organoids and mice.
Zafra MP, Schatoff EM, Katti A, Foronda M, Breinig M, Schweitzer AY, Simon A, Han T, Goswami S, Montgomery E, Thibado J, Kastenhuber ER, Sanchez-Rivera FJ, Shi J, Vakoc CR, Lowe SW, Tschaharganeh DF, Dow LE.
Nat Biotechnol. 2018 Jul 3. pii: nbt.4194. doi: 10.1038/nbt.4194.
PubMed
Associated Plasmids |
| Construction of non-canonical PAM-targeting adenosine base editors by restriction enzyme-free DNA cloning using CRISPR-Cas9. Jeong YK, Yu J, Bae S. Sci Rep. 2019 Mar 20;9(1):4939. doi: 10.1038/s41598-019-41356-1. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.